The Discounted Cash Flow (DCF) valuation of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 802.50 INR. With the latest stock price at 2,091.80 INR, the upside of Glenmark Pharmaceuticals Ltd based on DCF is -61.6%.
Based on the latest price of 2,091.80 INR and our DCF valuation, Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is a sell. selling GLENMARK.NS stocks now will result in a potential gain of 61.6%.
| Range | Selected | |
| WACC / Discount Rate | 11.1% - 13.4% | 12.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 663.97 - 1,038.64 | 802.50 |
| Upside | -68.3% - -50.3% | -61.6% |